Back HIV/AIDS

HIV / AIDS

Sweden Becomes First Country to Achieve UNAIDS 90-90-90 Targets

Sweden has become the first country to achieve the UNAIDS/World Health Organization (WHO) 90-90-90 targets, research published in the August 18 advance edition of HIV Medicine shows. At the end of 2015, 90% of HIV cases in Sweden were diagnosed, 99.8% of people were linked to care, and 95% of people taking antiretroviral therapy for at least 6 months had a viral load below 50 copies/mL.

alt

USCA 2016: U.S. Conference on AIDS Discusses HIV Prevention and Access to Care

The U.S. Conference on AIDS (USCA 201c), sponsored by the National Minority AIDS Council,is taking place this week, September 15-18, in Hollywood, Florida. The largest U.S. conference focused on the community-based response to HIV/AIDS, USCA brings together researchers, front-line providers, community organizations, government policymakers, and people living with HIV and their advocates to discuss how to improve access to HIV prevention, care, and treatment.

alt

AIDS 2016: Realism Needed About the Benefits and Risks of Taking Part in HIV Cure Research

A significant proportion of people living with HIV would be willing to take part in a study towards a cure for HIV, according to research presented at the recent 21st International AIDS Conference (AIDS 2016) in Durban. However, some potential participants may not fully understand that taking part in an early-phase study is highly unlikely to afford any personal clinical benefit, but might have the potential to cause harm.

alt

Nationwide PrEP Search Engine Debuts at U.S. Conference on AIDS

Emory University and partners have developed a new web-based directory of PrEP providers across the U.S., launching the project at the U.S. Conference on AIDS taking place this week in Hollywood, Florida. The search engine can be used to help people find physicians or clinics in their area that will prescribe Truvada (tenofovir/emtricitabine) for HIV prevention.

alt

AIDS 2016: HIV Will Only Be Cured with Combined Approaches, Conference Delegates Hear

Curing people of HIV infection will have to involve combinations of drugs and approaches, just as HIV treatment does, delegates heard at the Towards an HIV Cure workshop held in advance of the recent 21st International AIDS Conference (AIDS 2016) in Durban. The reason is the same, too: HIV can easily develop resistance to single agents, even ones as sophisticated as broadly neutralizing antibodies and gene-editing enzymes.

alt

AIDS 2016: Vaginal Ring for HIV Prevention is Effective and Acceptable

An updated adherence analysis from the ASPIRE study indicates that consistent users of a vaginal ring containing dapivirine experienced 65% fewer HIV infections, according to a presentation at the recent 21st International AIDS Conference (AIDS 2016) in Durban. Moreover, African women who took part in the study told researchers that they liked the product, found it easy to use, and preferred it to possible alternatives such as tablets or vaginal gels.

alt

AIDS 2016: Neglect of Infectious Disease in Prisons Highlighted at Conference

A special issue of The Lancet was published to coincide with the recent 21st International AIDS Conference in Durban, containing a comprehensive seriesof reviews on the burden of HIV, hepatitis B, hepatitis C, and tuberculosis (TB) among prisoners worldwide.

alt